Patricia Rayman

4PUBLICATIONS
33CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 17, 2025
Responses to checkpoint inhibition in metastatic triple negative breast cancer driven by divergent myeloid phenotypes.

Avia D Wilkerson, Ivan Juric, Salendra Singh

|Nov 30, 2023
Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with Melanoma.

Alan Shen, Michelle Arbesman, Roshan Lodha

|Oct 26, 2023
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.

Avia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini

Pageof 1